Added to YB: 2019-06-11
Pitch date: 2019-06-11
KALV [bullish]
KalVista Pharmaceuticals, Inc.
-8.4%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.
Market Cap
$532.5M
Pitch Price
$18.46
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.60
P/E
-2.88
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
KALVISTA PHARMACEUTICALS KALV
A summary for this pitch has not been created yet.
Read full article (0 min)